Advertisement
Advertisement
IMDX
Insight Molecular Diagnostics Inc. Common Stock
2.47
USDSponsored
-0.03
-1.20%
Nov 10, 15:59 UTC -5
Closed
After-Market
2.48
+0.01
+0.61%
Insight Molecular Diagnostics Inc. Common Stock (IMDX) Earnings
IMDX Earnings Reports
Positive Surprise Ratio
IMDX beat 16 of 43 last estimates.
37%
Next Report
Next Week
Date of Next Report
Nov 16, 2026
Estimate for Q3 26 (Revenue/ EPS)
$249.08K
/-$0.24
Implied change from Q2 26 (Revenue/ EPS)
+4.22%
/-22.58%
Implied change from Q3 25 (Revenue/ EPS)
-4.20%
/-29.41%
Insight Molecular Diagnostics Inc. Common Stock earnings per share and revenue
On Aug 10, 2026, IMDX reported earnings of -0.31 USD per share (EPS) for Q2 26, missing the estimate of -0.24 USD, resulting in a -24.45% surprise. Revenue reached 239.00 thousand, compared to an expected 446.25 thousand, with a -46.44% difference. The market reacted with a -7.13% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 249.08 thousand USD, implying an decrease of -22.58% EPS, and increase of 4.22% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Azenta, Inc.
Report Date
Nov 10, 2026 For Q4 26
Estimate
$0.11
Actual
$0.28
Surprise
+153.62%
Fulgent Genetics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.66
Actual
-$0.09
Surprise
+86.43%
Evolent Health, Inc Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.05
Actual
$0.06
Surprise
+13.21%
Carlsmed, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.40
Actual
-$0.34
Surprise
+16.79%
Claritev Corporation
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$3.69
Actual
-$3.64
Surprise
+1.60%
Senseonics Holdings, Inc. Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.52
Actual
-$0.50
Surprise
+5.05%
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.01
Actual
$0.00
Surprise
+100.00%
CareCloud, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.11
Actual
$0.14
Surprise
+19.35%
Neuraxis, Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.34
Actual
-$0.52
Surprise
-49.94%
Hims & Hers Health, Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.06
Actual
$0.03
Surprise
-53.78%
FAQ
What were Insight Molecular Diagnostics Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Insight Molecular Diagnostics Inc. Common Stock reported EPS of -$0.31, missing estimates by -24.45%, and revenue of $239.00K, -46.44% below expectations.
How did the market react to Insight Molecular Diagnostics Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -7.13%, changed from $4.77 before the earnings release to $4.43 the day after.
When is Insight Molecular Diagnostics Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 16, 2026.
What are the forecasts for Insight Molecular Diagnostics Inc. Common Stock's next earnings report?
Based on 5
analysts, Insight Molecular Diagnostics Inc. Common Stock is expected to report EPS of -$0.24 and revenue of $249.08K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.